Drug Profile
PAN 346
Alternative Names: PAN-346Latest Information Update: 17 May 2018
Price :
$50
*
At a glance
- Originator Panacea Pharmaceuticals
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaplastic astrocytoma; Glioblastoma
Most Recent Events
- 16 May 2018 Panacea Pharmaceuticals is now called Sensei Biotherapeutics
- 03 Apr 2003 No development reported - Preclinical for Anaplastic astrocytoma in USA (unspecified route)
- 03 Apr 2003 No development reported - Preclinical for Glioblastoma in USA (unspecified route)